Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19

Antecedent use of renin-angiotensin system inhibitors (RASi) prevents clinical deterioration and protects against cardiovascular/thrombotic complications of COVID-19, for indicated patients. Uncertainty exists regarding treatment continuation throughout infection and doing so with concomitant medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Palazzuoli, Alberto, Tecson, Kristen M., Vicenzi, Marco, D'Ascenzo, Fabrizio, De Ferrari, Gaetano Maria, Monticone, Silvia, Secco, Gioel G., Tavazzi, Guido, Forleo, Giovanni, Severino, Paolo, Fedele, Francesco, De Rosa, Francesco, McCullough, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744009/
https://www.ncbi.nlm.nih.gov/pubmed/35027137
http://dx.doi.org/10.1016/j.amjcard.2021.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744009/
https://www.ncbi.nlm.nih.gov/pubmed/35027137
http://dx.doi.org/10.1016/j.amjcard.2021.12.004

Ejemplares similares